Industries > Pharma > Automation in Biopharma Industry 2020-2030

Automation in Biopharma Industry 2020-2030

Automation in Biopharma Industry 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis for Automation in Biopharma

PUBLISHED: 30 April 2020
PAGES: 142
PRODUCT CODE: PHA0455

Clear
WOOCS 2.2.1

The automation in biopharma industry market is estimated to grow at a CAGR of 4.3% over the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The 142-page Visiongain report provides clear detailed insight into the automation in biopharma market. Discover the key trends and development in the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global automation in biopharma market forecasts from 2020-2030

• This report also breaks down the revenue forecast to 2030 for the global automation in biopharma market by applications & leading technology type:

• By Application:
• Global automation and digital market in biopharmaceutical industry in clinical stage
• Global automation and digital market in biopharmaceutical industry in drug discovery stage

• By Technology:

• Automation Technology
• DCS
• SCADA
• PLC
• MES
• HMI
• APC
• ERP
• LIMS
• CRM
• CAPA

• Digitization Technology
• IoT
• AI
• Digital Twin
• AR & VR
• Predictive Analytics
• Cloud Computing

This report discusses the market trends and developments of each submarket.

• Our study discusses the selected leading companies that are the major players in the automation in biopharma market:
• PerkinElmer
• Thermo Fisher Scientific
• Sartorius
• Siemens
• Rockwell Automation
• & Other Companies

Visiongain’s study is intended for anyone requiring commercial analyses for the global automation in biopharma market. You find data, trends and predictions.

Buy our report today Automation in Biopharma Industry  Research 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Automation in Biopharma Industry 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Automation in Biopharma Industry 2020-2030


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories